Chai Discovery

Design suite for molecules

Chai Discovery builds a design suite for molecules, training frontier models that learn the underlying rules of biochemical structure and interaction. The point is reach as much as speed: scientists can pursue targets that other computational methods cannot get to. Leading pharmaceutical companies including Eli Lilly, Pfizer and Novartis run the platform inside their drug discovery programmes. The team works at high velocity with individual ownership over the work.